nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—UGT2B7—Epirubicin—thyroid cancer	0.345	0.422	CbGbCtD
Codeine—CYP3A7—Sorafenib—thyroid cancer	0.106	0.13	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.106	0.13	CbGbCtD
Codeine—CYP3A5—Sorafenib—thyroid cancer	0.0796	0.0975	CbGbCtD
Codeine—CYP3A4—Vandetanib—thyroid cancer	0.0515	0.0631	CbGbCtD
Codeine—CYP2D6—Sorafenib—thyroid cancer	0.0488	0.0598	CbGbCtD
Codeine—CYP3A4—Sorafenib—thyroid cancer	0.031	0.038	CbGbCtD
Codeine—CYP2D6—Doxorubicin—thyroid cancer	0.0296	0.0363	CbGbCtD
Codeine—CYP3A4—Doxorubicin—thyroid cancer	0.0188	0.0231	CbGbCtD
Codeine—Respiratory arrest—Vandetanib—thyroid cancer	0.00932	0.0519	CcSEcCtD
Codeine—Rhinorrhoea—Sorafenib—thyroid cancer	0.00341	0.019	CcSEcCtD
Codeine—Bone disorder—Sorafenib—thyroid cancer	0.00306	0.017	CcSEcCtD
Codeine—Cardiac arrest—Vandetanib—thyroid cancer	0.00283	0.0157	CcSEcCtD
Codeine—Dehydration—Vandetanib—thyroid cancer	0.00277	0.0154	CcSEcCtD
Codeine—Nasopharyngitis—Vandetanib—thyroid cancer	0.00266	0.0148	CcSEcCtD
Codeine—Pancreatitis—Vandetanib—thyroid cancer	0.00252	0.014	CcSEcCtD
Codeine—Depression—Vandetanib—thyroid cancer	0.00229	0.0127	CcSEcCtD
Codeine—Bradycardia—Vandetanib—thyroid cancer	0.00209	0.0117	CcSEcCtD
Codeine—Urinary tract disorder—Vandetanib—thyroid cancer	0.00203	0.0113	CcSEcCtD
Codeine—Urethral disorder—Vandetanib—thyroid cancer	0.00202	0.0112	CcSEcCtD
Codeine—Visual impairment—Vandetanib—thyroid cancer	0.00198	0.011	CcSEcCtD
Codeine—Eye disorder—Vandetanib—thyroid cancer	0.00192	0.0107	CcSEcCtD
Codeine—Cardiac disorder—Vandetanib—thyroid cancer	0.00191	0.0106	CcSEcCtD
Codeine—Mood swings—Sorafenib—thyroid cancer	0.0019	0.0106	CcSEcCtD
Codeine—Dehydration—Sorafenib—thyroid cancer	0.00187	0.0104	CcSEcCtD
Codeine—Mediastinal disorder—Vandetanib—thyroid cancer	0.00185	0.0103	CcSEcCtD
Codeine—Hypothermia—Epirubicin—thyroid cancer	0.00182	0.0101	CcSEcCtD
Codeine—Body temperature decreased—Epirubicin—thyroid cancer	0.00182	0.0101	CcSEcCtD
Codeine—Breast disorder—Sorafenib—thyroid cancer	0.00181	0.0101	CcSEcCtD
Codeine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00179	0.00999	CcSEcCtD
Codeine—Lacrimation—Epirubicin—thyroid cancer	0.00174	0.00967	CcSEcCtD
Codeine—Muscle spasms—Vandetanib—thyroid cancer	0.00172	0.00958	CcSEcCtD
Codeine—Pancreatitis—Sorafenib—thyroid cancer	0.0017	0.00946	CcSEcCtD
Codeine—Body temperature decreased—Doxorubicin—thyroid cancer	0.00169	0.00938	CcSEcCtD
Codeine—Hypothermia—Doxorubicin—thyroid cancer	0.00169	0.00938	CcSEcCtD
Codeine—Tremor—Vandetanib—thyroid cancer	0.00168	0.00934	CcSEcCtD
Codeine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00166	0.00925	CcSEcCtD
Codeine—Lacrimation—Doxorubicin—thyroid cancer	0.00161	0.00895	CcSEcCtD
Codeine—Loss of consciousness—Vandetanib—thyroid cancer	0.00157	0.00876	CcSEcCtD
Codeine—Convulsion—Vandetanib—thyroid cancer	0.00155	0.00864	CcSEcCtD
Codeine—Anxiety—Vandetanib—thyroid cancer	0.00152	0.00846	CcSEcCtD
Codeine—Redness—Epirubicin—thyroid cancer	0.00151	0.00842	CcSEcCtD
Codeine—Dry mouth—Vandetanib—thyroid cancer	0.00149	0.0083	CcSEcCtD
Codeine—Nervous system disorder—Vandetanib—thyroid cancer	0.00143	0.00798	CcSEcCtD
Codeine—Redness—Doxorubicin—thyroid cancer	0.0014	0.00779	CcSEcCtD
Codeine—Urinary tract disorder—Sorafenib—thyroid cancer	0.00137	0.00763	CcSEcCtD
Codeine—Urethral disorder—Sorafenib—thyroid cancer	0.00136	0.00757	CcSEcCtD
Codeine—Insomnia—Vandetanib—thyroid cancer	0.00132	0.00736	CcSEcCtD
Codeine—Dyspnoea—Vandetanib—thyroid cancer	0.0013	0.00725	CcSEcCtD
Codeine—Flushing—Sorafenib—thyroid cancer	0.00129	0.00717	CcSEcCtD
Codeine—Cardiac disorder—Sorafenib—thyroid cancer	0.00129	0.00717	CcSEcCtD
Codeine—Decreased appetite—Vandetanib—thyroid cancer	0.00127	0.00707	CcSEcCtD
Codeine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00126	0.00702	CcSEcCtD
Codeine—Fatigue—Vandetanib—thyroid cancer	0.00126	0.00701	CcSEcCtD
Codeine—Immune system disorder—Sorafenib—thyroid cancer	0.00125	0.00698	CcSEcCtD
Codeine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00125	0.00696	CcSEcCtD
Codeine—Constipation—Vandetanib—thyroid cancer	0.00125	0.00696	CcSEcCtD
Codeine—Erythema—Sorafenib—thyroid cancer	0.00121	0.00673	CcSEcCtD
Codeine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0012	0.00665	CcSEcCtD
Codeine—Muscle spasms—Sorafenib—thyroid cancer	0.00116	0.00647	CcSEcCtD
Codeine—Abdominal pain—Vandetanib—thyroid cancer	0.00116	0.00643	CcSEcCtD
Codeine—Body temperature increased—Vandetanib—thyroid cancer	0.00116	0.00643	CcSEcCtD
Codeine—Bone disorder—Epirubicin—thyroid cancer	0.00113	0.00629	CcSEcCtD
Codeine—Lacrimation increased—Epirubicin—thyroid cancer	0.00111	0.00617	CcSEcCtD
Codeine—Angioedema—Sorafenib—thyroid cancer	0.0011	0.00614	CcSEcCtD
Codeine—Syncope—Sorafenib—thyroid cancer	0.00108	0.00603	CcSEcCtD
Codeine—Loss of consciousness—Sorafenib—thyroid cancer	0.00106	0.00591	CcSEcCtD
Codeine—Asthenia—Vandetanib—thyroid cancer	0.00105	0.00584	CcSEcCtD
Codeine—Bone disorder—Doxorubicin—thyroid cancer	0.00105	0.00582	CcSEcCtD
Codeine—Pruritus—Vandetanib—thyroid cancer	0.00103	0.00576	CcSEcCtD
Codeine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00103	0.00571	CcSEcCtD
Codeine—Dry mouth—Sorafenib—thyroid cancer	0.00101	0.0056	CcSEcCtD
Codeine—Shock—Sorafenib—thyroid cancer	0.00097	0.0054	CcSEcCtD
Codeine—Nervous system disorder—Sorafenib—thyroid cancer	0.000967	0.00538	CcSEcCtD
Codeine—Dizziness—Vandetanib—thyroid cancer	0.000967	0.00538	CcSEcCtD
Codeine—Anorexia—Sorafenib—thyroid cancer	0.00094	0.00523	CcSEcCtD
Codeine—Vomiting—Vandetanib—thyroid cancer	0.000929	0.00517	CcSEcCtD
Codeine—Rash—Vandetanib—thyroid cancer	0.000922	0.00513	CcSEcCtD
Codeine—Dermatitis—Vandetanib—thyroid cancer	0.000921	0.00513	CcSEcCtD
Codeine—Dyspnoea—Sorafenib—thyroid cancer	0.000879	0.00489	CcSEcCtD
Codeine—Nausea—Vandetanib—thyroid cancer	0.000868	0.00483	CcSEcCtD
Codeine—Decreased appetite—Sorafenib—thyroid cancer	0.000857	0.00477	CcSEcCtD
Codeine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000851	0.00474	CcSEcCtD
Codeine—Fatigue—Sorafenib—thyroid cancer	0.00085	0.00473	CcSEcCtD
Codeine—Constipation—Sorafenib—thyroid cancer	0.000843	0.00469	CcSEcCtD
Codeine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000806	0.00449	CcSEcCtD
Codeine—Urticaria—Sorafenib—thyroid cancer	0.000783	0.00436	CcSEcCtD
Codeine—Body temperature increased—Sorafenib—thyroid cancer	0.00078	0.00434	CcSEcCtD
Codeine—Abdominal pain—Sorafenib—thyroid cancer	0.00078	0.00434	CcSEcCtD
Codeine—Diplopia—Epirubicin—thyroid cancer	0.000742	0.00413	CcSEcCtD
Codeine—Affect lability—Epirubicin—thyroid cancer	0.00073	0.00406	CcSEcCtD
Codeine—Hypersensitivity—Sorafenib—thyroid cancer	0.000727	0.00404	CcSEcCtD
Codeine—Asthenia—Sorafenib—thyroid cancer	0.000708	0.00394	CcSEcCtD
Codeine—Cardiac arrest—Epirubicin—thyroid cancer	0.000705	0.00392	CcSEcCtD
Codeine—Mood swings—Epirubicin—thyroid cancer	0.000702	0.00391	CcSEcCtD
Codeine—Pruritus—Sorafenib—thyroid cancer	0.000698	0.00388	CcSEcCtD
Codeine—Dehydration—Epirubicin—thyroid cancer	0.00069	0.00384	CcSEcCtD
Codeine—Diplopia—Doxorubicin—thyroid cancer	0.000686	0.00382	CcSEcCtD
Codeine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000677	0.00377	CcSEcCtD
Codeine—Affect lability—Doxorubicin—thyroid cancer	0.000675	0.00376	CcSEcCtD
Codeine—Breast disorder—Epirubicin—thyroid cancer	0.00067	0.00373	CcSEcCtD
Codeine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000663	0.00369	CcSEcCtD
Codeine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000652	0.00363	CcSEcCtD
Codeine—Dizziness—Sorafenib—thyroid cancer	0.000652	0.00363	CcSEcCtD
Codeine—Mood swings—Doxorubicin—thyroid cancer	0.00065	0.00362	CcSEcCtD
Codeine—Dehydration—Doxorubicin—thyroid cancer	0.000638	0.00355	CcSEcCtD
Codeine—Pancreatitis—Epirubicin—thyroid cancer	0.000628	0.0035	CcSEcCtD
Codeine—Vomiting—Sorafenib—thyroid cancer	0.000627	0.00349	CcSEcCtD
Codeine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000627	0.00349	CcSEcCtD
Codeine—Rash—Sorafenib—thyroid cancer	0.000622	0.00346	CcSEcCtD
Codeine—Dermatitis—Sorafenib—thyroid cancer	0.000621	0.00346	CcSEcCtD
Codeine—Breast disorder—Doxorubicin—thyroid cancer	0.00062	0.00345	CcSEcCtD
Codeine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000614	0.00341	CcSEcCtD
Codeine—Nausea—Sorafenib—thyroid cancer	0.000586	0.00326	CcSEcCtD
Codeine—Pancreatitis—Doxorubicin—thyroid cancer	0.000581	0.00324	CcSEcCtD
Codeine—Drowsiness—Epirubicin—thyroid cancer	0.000571	0.00318	CcSEcCtD
Codeine—Sweating—Epirubicin—thyroid cancer	0.000548	0.00305	CcSEcCtD
Codeine—Drowsiness—Doxorubicin—thyroid cancer	0.000529	0.00294	CcSEcCtD
Codeine—Bradycardia—Epirubicin—thyroid cancer	0.000522	0.00291	CcSEcCtD
Codeine—Sweating—Doxorubicin—thyroid cancer	0.000507	0.00282	CcSEcCtD
Codeine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000507	0.00282	CcSEcCtD
Codeine—Urethral disorder—Epirubicin—thyroid cancer	0.000503	0.0028	CcSEcCtD
Codeine—Visual impairment—Epirubicin—thyroid cancer	0.000494	0.00275	CcSEcCtD
Codeine—Bradycardia—Doxorubicin—thyroid cancer	0.000483	0.00269	CcSEcCtD
Codeine—Eye disorder—Epirubicin—thyroid cancer	0.000479	0.00267	CcSEcCtD
Codeine—Cardiac disorder—Epirubicin—thyroid cancer	0.000476	0.00265	CcSEcCtD
Codeine—Flushing—Epirubicin—thyroid cancer	0.000476	0.00265	CcSEcCtD
Codeine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000469	0.00261	CcSEcCtD
Codeine—Urethral disorder—Doxorubicin—thyroid cancer	0.000465	0.00259	CcSEcCtD
Codeine—Immune system disorder—Epirubicin—thyroid cancer	0.000463	0.00258	CcSEcCtD
Codeine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000462	0.00257	CcSEcCtD
Codeine—Visual impairment—Doxorubicin—thyroid cancer	0.000457	0.00255	CcSEcCtD
Codeine—Erythema—Epirubicin—thyroid cancer	0.000447	0.00249	CcSEcCtD
Codeine—Eye disorder—Doxorubicin—thyroid cancer	0.000444	0.00247	CcSEcCtD
Codeine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000441	0.00245	CcSEcCtD
Codeine—Flushing—Doxorubicin—thyroid cancer	0.000441	0.00245	CcSEcCtD
Codeine—Tension—Epirubicin—thyroid cancer	0.000438	0.00244	CcSEcCtD
Codeine—Nervousness—Epirubicin—thyroid cancer	0.000434	0.00241	CcSEcCtD
Codeine—Muscle spasms—Epirubicin—thyroid cancer	0.000429	0.00239	CcSEcCtD
Codeine—Immune system disorder—Doxorubicin—thyroid cancer	0.000429	0.00239	CcSEcCtD
Codeine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000428	0.00238	CcSEcCtD
Codeine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000414	0.00231	CcSEcCtD
Codeine—Erythema—Doxorubicin—thyroid cancer	0.000413	0.0023	CcSEcCtD
Codeine—Agitation—Epirubicin—thyroid cancer	0.00041	0.00228	CcSEcCtD
Codeine—Tension—Doxorubicin—thyroid cancer	0.000405	0.00226	CcSEcCtD
Codeine—Malaise—Epirubicin—thyroid cancer	0.000403	0.00224	CcSEcCtD
Codeine—Nervousness—Doxorubicin—thyroid cancer	0.000401	0.00223	CcSEcCtD
Codeine—Vertigo—Epirubicin—thyroid cancer	0.000401	0.00223	CcSEcCtD
Codeine—Syncope—Epirubicin—thyroid cancer	0.0004	0.00223	CcSEcCtD
Codeine—Muscle spasms—Doxorubicin—thyroid cancer	0.000397	0.00221	CcSEcCtD
Codeine—Palpitations—Epirubicin—thyroid cancer	0.000395	0.0022	CcSEcCtD
Codeine—Loss of consciousness—Epirubicin—thyroid cancer	0.000392	0.00218	CcSEcCtD
Codeine—Convulsion—Epirubicin—thyroid cancer	0.000387	0.00215	CcSEcCtD
Codeine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000383	0.00213	CcSEcCtD
Codeine—Agitation—Doxorubicin—thyroid cancer	0.00038	0.00211	CcSEcCtD
Codeine—Anxiety—Epirubicin—thyroid cancer	0.000379	0.00211	CcSEcCtD
Codeine—Discomfort—Epirubicin—thyroid cancer	0.000376	0.00209	CcSEcCtD
Codeine—Malaise—Doxorubicin—thyroid cancer	0.000373	0.00207	CcSEcCtD
Codeine—Dry mouth—Epirubicin—thyroid cancer	0.000372	0.00207	CcSEcCtD
Codeine—Vertigo—Doxorubicin—thyroid cancer	0.000371	0.00207	CcSEcCtD
Codeine—Syncope—Doxorubicin—thyroid cancer	0.000371	0.00206	CcSEcCtD
Codeine—Confusional state—Epirubicin—thyroid cancer	0.000367	0.00205	CcSEcCtD
Codeine—Palpitations—Doxorubicin—thyroid cancer	0.000365	0.00203	CcSEcCtD
Codeine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000363	0.00202	CcSEcCtD
Codeine—Shock—Epirubicin—thyroid cancer	0.000359	0.002	CcSEcCtD
Codeine—Convulsion—Doxorubicin—thyroid cancer	0.000358	0.00199	CcSEcCtD
Codeine—Nervous system disorder—Epirubicin—thyroid cancer	0.000357	0.00199	CcSEcCtD
Codeine—Tachycardia—Epirubicin—thyroid cancer	0.000356	0.00198	CcSEcCtD
Codeine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000352	0.00196	CcSEcCtD
Codeine—Anxiety—Doxorubicin—thyroid cancer	0.000351	0.00195	CcSEcCtD
Codeine—Discomfort—Doxorubicin—thyroid cancer	0.000348	0.00193	CcSEcCtD
Codeine—Anorexia—Epirubicin—thyroid cancer	0.000347	0.00193	CcSEcCtD
Codeine—Dry mouth—Doxorubicin—thyroid cancer	0.000344	0.00191	CcSEcCtD
Codeine—Hypotension—Epirubicin—thyroid cancer	0.000341	0.0019	CcSEcCtD
Codeine—Confusional state—Doxorubicin—thyroid cancer	0.00034	0.00189	CcSEcCtD
Codeine—Shock—Doxorubicin—thyroid cancer	0.000332	0.00185	CcSEcCtD
Codeine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000331	0.00184	CcSEcCtD
Codeine—Insomnia—Epirubicin—thyroid cancer	0.00033	0.00183	CcSEcCtD
Codeine—Tachycardia—Doxorubicin—thyroid cancer	0.000329	0.00183	CcSEcCtD
Codeine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000326	0.00181	CcSEcCtD
Codeine—Dyspnoea—Epirubicin—thyroid cancer	0.000325	0.00181	CcSEcCtD
Codeine—Somnolence—Epirubicin—thyroid cancer	0.000324	0.0018	CcSEcCtD
Codeine—Anorexia—Doxorubicin—thyroid cancer	0.000321	0.00179	CcSEcCtD
Codeine—Decreased appetite—Epirubicin—thyroid cancer	0.000317	0.00176	CcSEcCtD
Codeine—Hypotension—Doxorubicin—thyroid cancer	0.000315	0.00175	CcSEcCtD
Codeine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000315	0.00175	CcSEcCtD
Codeine—Fatigue—Epirubicin—thyroid cancer	0.000314	0.00175	CcSEcCtD
Codeine—Constipation—Epirubicin—thyroid cancer	0.000312	0.00173	CcSEcCtD
Codeine—Insomnia—Doxorubicin—thyroid cancer	0.000305	0.0017	CcSEcCtD
Codeine—Dyspnoea—Doxorubicin—thyroid cancer	0.000301	0.00167	CcSEcCtD
Codeine—Feeling abnormal—Epirubicin—thyroid cancer	0.0003	0.00167	CcSEcCtD
Codeine—Somnolence—Doxorubicin—thyroid cancer	0.0003	0.00167	CcSEcCtD
Codeine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000298	0.00166	CcSEcCtD
Codeine—Decreased appetite—Doxorubicin—thyroid cancer	0.000293	0.00163	CcSEcCtD
Codeine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000291	0.00162	CcSEcCtD
Codeine—Fatigue—Doxorubicin—thyroid cancer	0.000291	0.00162	CcSEcCtD
Codeine—Urticaria—Epirubicin—thyroid cancer	0.00029	0.00161	CcSEcCtD
Codeine—Constipation—Doxorubicin—thyroid cancer	0.000288	0.0016	CcSEcCtD
Codeine—Abdominal pain—Epirubicin—thyroid cancer	0.000288	0.0016	CcSEcCtD
Codeine—Body temperature increased—Epirubicin—thyroid cancer	0.000288	0.0016	CcSEcCtD
Codeine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000278	0.00155	CcSEcCtD
Codeine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000276	0.00153	CcSEcCtD
Codeine—Hypersensitivity—Epirubicin—thyroid cancer	0.000269	0.00149	CcSEcCtD
Codeine—Urticaria—Doxorubicin—thyroid cancer	0.000268	0.00149	CcSEcCtD
Codeine—Abdominal pain—Doxorubicin—thyroid cancer	0.000267	0.00148	CcSEcCtD
Codeine—Body temperature increased—Doxorubicin—thyroid cancer	0.000267	0.00148	CcSEcCtD
Codeine—Asthenia—Epirubicin—thyroid cancer	0.000261	0.00146	CcSEcCtD
Codeine—Pruritus—Epirubicin—thyroid cancer	0.000258	0.00144	CcSEcCtD
Codeine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000248	0.00138	CcSEcCtD
Codeine—Asthenia—Doxorubicin—thyroid cancer	0.000242	0.00135	CcSEcCtD
Codeine—Dizziness—Epirubicin—thyroid cancer	0.000241	0.00134	CcSEcCtD
Codeine—Pruritus—Doxorubicin—thyroid cancer	0.000239	0.00133	CcSEcCtD
Codeine—Vomiting—Epirubicin—thyroid cancer	0.000232	0.00129	CcSEcCtD
Codeine—Rash—Epirubicin—thyroid cancer	0.00023	0.00128	CcSEcCtD
Codeine—Dermatitis—Epirubicin—thyroid cancer	0.00023	0.00128	CcSEcCtD
Codeine—Dizziness—Doxorubicin—thyroid cancer	0.000223	0.00124	CcSEcCtD
Codeine—Nausea—Epirubicin—thyroid cancer	0.000216	0.0012	CcSEcCtD
Codeine—Vomiting—Doxorubicin—thyroid cancer	0.000214	0.00119	CcSEcCtD
Codeine—Rash—Doxorubicin—thyroid cancer	0.000213	0.00118	CcSEcCtD
Codeine—Dermatitis—Doxorubicin—thyroid cancer	0.000212	0.00118	CcSEcCtD
Codeine—Nausea—Doxorubicin—thyroid cancer	0.0002	0.00111	CcSEcCtD
Codeine—OPRM1—GPCR ligand binding—CALCB—thyroid cancer	3.18e-05	0.00916	CbGpPWpGaD
Codeine—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.18e-05	0.00915	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—SST—thyroid cancer	3.02e-05	0.00871	CbGpPWpGaD
Codeine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	2.94e-05	0.00846	CbGpPWpGaD
Codeine—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.83e-05	0.00816	CbGpPWpGaD
Codeine—UGT2B7—NRF2 pathway—RXRA—thyroid cancer	2.82e-05	0.00811	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—SST—thyroid cancer	2.65e-05	0.00764	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	2.61e-05	0.00751	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—HPGD—thyroid cancer	2.57e-05	0.00739	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—SST—thyroid cancer	2.55e-05	0.00735	CbGpPWpGaD
Codeine—UGT2B7—Biological oxidations—RXRA—thyroid cancer	2.47e-05	0.00711	CbGpPWpGaD
Codeine—UGT2B7—NRF2 pathway—NRG1—thyroid cancer	2.43e-05	0.00701	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CALCB—thyroid cancer	2.42e-05	0.00698	CbGpPWpGaD
Codeine—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.3e-05	0.00661	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	2.29e-05	0.00659	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—SST—thyroid cancer	2.24e-05	0.00645	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—SST—thyroid cancer	2.24e-05	0.00644	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CALCB—thyroid cancer	2.2e-05	0.00634	CbGpPWpGaD
Codeine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	2.18e-05	0.00627	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CALCB—thyroid cancer	2.13e-05	0.00612	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	2.03e-05	0.00584	CbGpPWpGaD
Codeine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.01e-05	0.0058	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—TSHR—thyroid cancer	1.99e-05	0.00572	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	1.93e-05	0.00557	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CALCB—thyroid cancer	1.93e-05	0.00556	CbGpPWpGaD
Codeine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	1.92e-05	0.00553	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—SST—thyroid cancer	1.89e-05	0.00544	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—MINPP1—thyroid cancer	1.81e-05	0.00523	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CALCB—thyroid cancer	1.8e-05	0.00517	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—CP—thyroid cancer	1.79e-05	0.00517	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	1.79e-05	0.00517	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	1.78e-05	0.00512	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—TSHR—thyroid cancer	1.74e-05	0.00502	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—PTCH1—thyroid cancer	1.69e-05	0.00486	CbGpPWpGaD
Codeine—CYP3A7—Biological oxidations—RXRA—thyroid cancer	1.69e-05	0.00486	CbGpPWpGaD
Codeine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.63e-05	0.0047	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CALCB—thyroid cancer	1.63e-05	0.0047	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—SST—thyroid cancer	1.54e-05	0.00445	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—NDUFA13—thyroid cancer	1.54e-05	0.00444	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	1.5e-05	0.00433	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CALCA—thyroid cancer	1.49e-05	0.00428	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—PTCH1—thyroid cancer	1.48e-05	0.00426	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—TPR—thyroid cancer	1.47e-05	0.00425	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—TSHR—thyroid cancer	1.47e-05	0.00424	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.00418	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—CHST14—thyroid cancer	1.45e-05	0.00418	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—SST—thyroid cancer	1.35e-05	0.0039	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.34e-05	0.00387	CbGpPWpGaD
Codeine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.32e-05	0.00379	CbGpPWpGaD
Codeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.31e-05	0.00377	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CALCA—thyroid cancer	1.3e-05	0.00375	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CALCB—thyroid cancer	1.3e-05	0.00375	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—PTCH1—thyroid cancer	1.25e-05	0.0036	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—MINPP1—thyroid cancer	1.24e-05	0.00357	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TRIM33—thyroid cancer	1.23e-05	0.00355	CbGpPWpGaD
Codeine—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.22e-05	0.00351	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—HPGD—thyroid cancer	1.17e-05	0.00337	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—MINPP1—thyroid cancer	1.15e-05	0.00332	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—SST—thyroid cancer	1.14e-05	0.0033	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CALCB—thyroid cancer	1.14e-05	0.00328	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—TSHR—thyroid cancer	1.12e-05	0.00323	CbGpPWpGaD
Codeine—OPRM1—IL4-mediated signaling events—AKT1—thyroid cancer	1.11e-05	0.00319	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—SLC5A5—thyroid cancer	1.1e-05	0.00318	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CALCA—thyroid cancer	1.1e-05	0.00317	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TRIM33—thyroid cancer	1.08e-05	0.00311	CbGpPWpGaD
Codeine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.07e-05	0.00308	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NDUFA13—thyroid cancer	1.05e-05	0.00304	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—TSHR—thyroid cancer	1.02e-05	0.00294	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—PRKAR1A—thyroid cancer	1e-05	0.00289	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—CHST14—thyroid cancer	9.91e-06	0.00285	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—TSHR—thyroid cancer	9.84e-06	0.00283	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NDUFA13—thyroid cancer	9.81e-06	0.00283	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CALCB—thyroid cancer	9.64e-06	0.00278	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—HRAS—thyroid cancer	9.31e-06	0.00268	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—RXRA—thyroid cancer	9.27e-06	0.00267	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CHST14—thyroid cancer	9.22e-06	0.00266	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TRIM33—thyroid cancer	9.13e-06	0.00263	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	9.12e-06	0.00263	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	9.12e-06	0.00263	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.97e-06	0.00258	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—MINPP1—thyroid cancer	8.96e-06	0.00258	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—TSHR—thyroid cancer	8.94e-06	0.00257	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—PRKAR1A—thyroid cancer	8.79e-06	0.00253	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—SST—thyroid cancer	8.73e-06	0.00251	CbGpPWpGaD
Codeine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	8.67e-06	0.0025	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—PTCH1—thyroid cancer	8.66e-06	0.0025	CbGpPWpGaD
Codeine—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	8.56e-06	0.00247	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CALCA—thyroid cancer	8.4e-06	0.00242	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—TSHR—thyroid cancer	8.32e-06	0.0024	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TCF7L1—thyroid cancer	8.22e-06	0.00237	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—AKT1—thyroid cancer	8.22e-06	0.00237	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—HPGD—thyroid cancer	7.99e-06	0.0023	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—SST—thyroid cancer	7.92e-06	0.00228	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—SST—thyroid cancer	7.65e-06	0.0022	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CALCA—thyroid cancer	7.63e-06	0.0022	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	7.62e-06	0.00219	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—PTCH1—thyroid cancer	7.6e-06	0.00219	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	7.55e-06	0.00218	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—HPGD—thyroid cancer	7.43e-06	0.00214	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	7.43e-06	0.00214	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	7.37e-06	0.00212	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	7.21e-06	0.00208	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CHST14—thyroid cancer	7.16e-06	0.00206	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—SST—thyroid cancer	6.95e-06	0.002	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CDK1—thyroid cancer	6.9e-06	0.00199	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.82e-06	0.00197	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—TPR—thyroid cancer	6.71e-06	0.00193	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	6.69e-06	0.00193	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	6.61e-06	0.0019	CbGpPWpGaD
Codeine—SLC22A1—Neuronal System—BRAF—thyroid cancer	6.56e-06	0.00189	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—SST—thyroid cancer	6.47e-06	0.00186	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	6.42e-06	0.00185	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—MINPP1—thyroid cancer	6.37e-06	0.00184	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	6.23e-06	0.00179	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	6.09e-06	0.00176	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	6.05e-06	0.00174	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TSHR—thyroid cancer	6.02e-06	0.00173	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	5.92e-06	0.00171	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—SST—thyroid cancer	5.87e-06	0.00169	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PPARG—thyroid cancer	5.85e-06	0.00169	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—HPGD—thyroid cancer	5.77e-06	0.00166	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.73e-06	0.00165	CbGpPWpGaD
Codeine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.67e-06	0.00163	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MEN1—thyroid cancer	5.66e-06	0.00163	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	5.65e-06	0.00163	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	5.42e-06	0.00156	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TSHR—thyroid cancer	5.28e-06	0.00152	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	5.19e-06	0.0015	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	5.12e-06	0.00147	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	5.12e-06	0.00147	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CHST14—thyroid cancer	5.09e-06	0.00147	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—SLC5A5—thyroid cancer	5.03e-06	0.00145	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MEN1—thyroid cancer	4.96e-06	0.00143	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—SST—thyroid cancer	4.68e-06	0.00135	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PTGS2—thyroid cancer	4.61e-06	0.00133	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—TPR—thyroid cancer	4.59e-06	0.00132	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	4.51e-06	0.0013	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CALCA—thyroid cancer	4.51e-06	0.0013	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	4.49e-06	0.00129	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TSHR—thyroid cancer	4.46e-06	0.00128	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	4.39e-06	0.00126	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—TPR—thyroid cancer	4.27e-06	0.00123	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—RXRA—thyroid cancer	4.22e-06	0.00122	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	4.2e-06	0.00121	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MEN1—thyroid cancer	4.19e-06	0.00121	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.17e-06	0.0012	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—HPGD—thyroid cancer	4.11e-06	0.00118	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—SST—thyroid cancer	4.1e-06	0.00118	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CDK1—thyroid cancer	4.08e-06	0.00117	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PTEN—thyroid cancer	4.02e-06	0.00116	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CALCA—thyroid cancer	3.95e-06	0.00114	CbGpPWpGaD
Codeine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.94e-06	0.00113	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	3.79e-06	0.00109	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CDK1—thyroid cancer	3.58e-06	0.00103	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.54e-06	0.00102	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—SST—thyroid cancer	3.47e-06	0.000999	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.43e-06	0.000989	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CALCA—thyroid cancer	3.34e-06	0.000962	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CHST14—thyroid cancer	3.33e-06	0.000959	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—TPR—thyroid cancer	3.32e-06	0.000955	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—NRG1—thyroid cancer	3.27e-06	0.000943	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.26e-06	0.00094	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	3.2e-06	0.000921	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CDK1—thyroid cancer	3.02e-06	0.000871	CbGpPWpGaD
Codeine—SLC22A1—Neuronal System—HRAS—thyroid cancer	3.02e-06	0.000868	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TERT—thyroid cancer	2.94e-06	0.000847	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—RXRA—thyroid cancer	2.89e-06	0.000831	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—NRG1—thyroid cancer	2.87e-06	0.000827	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	2.81e-06	0.00081	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—RXRA—thyroid cancer	2.69e-06	0.000774	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.68e-06	0.000773	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PPARG—thyroid cancer	2.67e-06	0.000768	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TERT—thyroid cancer	2.58e-06	0.000742	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.48e-06	0.000715	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	2.48e-06	0.000713	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	2.47e-06	0.00071	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—NRG1—thyroid cancer	2.43e-06	0.000699	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—TPR—thyroid cancer	2.36e-06	0.000679	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—BRAF—thyroid cancer	2.33e-06	0.000671	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.32e-06	0.000668	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—AKT1—thyroid cancer	2.31e-06	0.000667	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TERT—thyroid cancer	2.18e-06	0.000628	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	2.17e-06	0.000626	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	2.13e-06	0.000614	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PTGS2—thyroid cancer	2.1e-06	0.000604	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—RXRA—thyroid cancer	2.09e-06	0.000601	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	2.08e-06	0.0006	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—BRAF—thyroid cancer	2.04e-06	0.000588	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	1.87e-06	0.000538	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	1.84e-06	0.000529	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PTEN—thyroid cancer	1.83e-06	0.000527	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PPARG—thyroid cancer	1.82e-06	0.000525	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	1.81e-06	0.000522	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.77e-06	0.000509	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.76e-06	0.000507	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—BRAF—thyroid cancer	1.73e-06	0.000497	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCND1—thyroid cancer	1.7e-06	0.000489	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PPARG—thyroid cancer	1.7e-06	0.000488	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PTEN—thyroid cancer	1.64e-06	0.000472	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	1.6e-06	0.000461	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.59e-06	0.000458	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	1.58e-06	0.000455	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.54e-06	0.000445	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—TPR—thyroid cancer	1.54e-06	0.000444	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.52e-06	0.000437	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.49e-06	0.000429	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.48e-06	0.000427	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—NRAS—thyroid cancer	1.46e-06	0.000421	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1.44e-06	0.000414	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.43e-06	0.000413	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.4e-06	0.000404	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	1.34e-06	0.000387	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.33e-06	0.000384	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PPARG—thyroid cancer	1.32e-06	0.000379	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.31e-06	0.000376	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.28e-06	0.00037	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—KRAS—thyroid cancer	1.26e-06	0.000363	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCND1—thyroid cancer	1.26e-06	0.000363	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PTEN—thyroid cancer	1.25e-06	0.00036	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PTEN—thyroid cancer	1.22e-06	0.00035	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	1.19e-06	0.000342	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PTEN—thyroid cancer	1.16e-06	0.000335	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.15e-06	0.000332	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TP53—thyroid cancer	1.12e-06	0.000322	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.1e-06	0.000318	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—NRAS—thyroid cancer	1.08e-06	0.000312	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—HRAS—thyroid cancer	1.07e-06	0.000308	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—AKT1—thyroid cancer	1.05e-06	0.000304	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.04e-06	0.000298	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TP53—thyroid cancer	9.81e-07	0.000283	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—RXRA—thyroid cancer	9.7e-07	0.000279	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—AKT1—thyroid cancer	9.45e-07	0.000272	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—HRAS—thyroid cancer	9.39e-07	0.00027	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PPARG—thyroid cancer	9.37e-07	0.00027	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—KRAS—thyroid cancer	9.33e-07	0.000269	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PTEN—thyroid cancer	9.04e-07	0.00026	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TP53—thyroid cancer	8.29e-07	0.000239	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—AKT1—thyroid cancer	8.29e-07	0.000239	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—HRAS—thyroid cancer	7.93e-07	0.000228	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.37e-07	0.000212	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—AKT1—thyroid cancer	7.2e-07	0.000208	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—AKT1—thyroid cancer	7e-07	0.000202	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—AKT1—thyroid cancer	6.7e-07	0.000193	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.43e-07	0.000185	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PPARG—thyroid cancer	6.12e-07	0.000176	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—AKT1—thyroid cancer	5.21e-07	0.00015	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.82e-07	0.000139	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.2e-07	0.000121	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.7e-07	0.000107	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.42e-07	6.97e-05	CbGpPWpGaD
